Vitreous detachment
51 results
1 - 51- Vitreous detachment
- Retinal detachment
- Vitreous haemorrhage (VH)
- Interventions for prevention of giant retinal tear in the fellow eye
- Diabetic retinopathy
- Pars plana vitrectomy versus scleral buckling for repairing simple rhegmatogenous retinal detachments: Cochrane systematic review
- Pneumatic retinopexy versus scleral buckle for repairing simple rhegmatogenous retinal detachments
- Pars plana vitrectomy combined with scleral buckle versus pars plana vitrectomy for giant retinal tear
- Acute-onset visual floaters and flashes and the risk for retinal detachment
- Interventions for asymptomatic retinal breaks and lattice degeneration for preventing retinal detachment
- Impaired vision
- Eye examination
- Nd:YAG laser vitreolysis versus pars plana vitrectomy for vitreous floaters: Cochrane systematic review
- Face‐down positioning or posturing after pars plana vitrectomy for macula‐involving rhegmatogenous retinal detachments
- Surgery for postvitrectomy cataract: Cochrane systematic review
- Vitrectomy with internal limiting membrane (ILM) peeling versus vitrectomy with no peeling for idiopathic full-thickness macular hole (FTMH): Cochrane systematic review
- Anti‐vascular endothelial growth factors in combination with vitrectomy for complications of proliferative diabetic retinopathy
- Anti‐vascular endothelial growth factor (VEGF) drugs for treatment of retinopathy of prematurity
- Vitrectomy for idiopathic macular hole: Cochrane systematic review
- Non‐biologic, steroid‐sparing therapies for non‐infectious intermediate, posterior, and panuveitis in adults
- Comprehensive treatment and follow-up of type 2 diabetes
- Peripheral retinal ablation for threshold retinopathy of prematurity in preterm infants
- Ocriplasmin for symptomatic vitreomacular adhesion
- Laser photocoagulation for proliferative diabetic retinopathy
- Laser therapy for retinopathy in sickle cell disease
- Prognostic factors for the development and progression of proliferative diabetic retinopathy in people with diabetic retinopathy
- Adjunctive steroid therapy versus antibiotics alone for acute endophthalmitis after intraocular procedure
- Anti‐vascular endothelial growth factor for neovascular glaucoma